A new heterologous fibrin sealant as scaffold to recombinant human bone morphogenetic protein-2 (rhBMP-2) and natural latex proteins for the repair of tibial bone defects

被引:37
|
作者
Machado, Eduardo Gomes [1 ]
Mardegan Issa, Joao Paulo [2 ]
Tocchini de Figueiredo, Fellipe Augusto [2 ]
dos Santos, Geovane Ribeiro [1 ]
Galdeano, Ewerton Alexandre [1 ]
Alves, Mariana Carla [1 ]
Chacon, Erivelto Luis [1 ]
Ferreira Junior, Rui Seabra [3 ]
Barraviera, Benedito [3 ]
da Cunha, Marcelo Rodrigues [1 ]
机构
[1] Sch Med Jundiai, Dept Morphol & Pathol, BR-13202550 Jundiai, SP, Brazil
[2] Univ Sao Paulo, Dent Sch Ribeirao Preto, Dept Morphol Stomatol & Physiol, BR-14040904 Ribeirao Preto, SP, Brazil
[3] Sao Paulo State Univ UNESP Univ Estadual Paulista, Ctr Study Venoms & Venomous Anim CEVAP, BR-18610307 Botucatu, SP, Brazil
关键词
Fibrin; Sealant; Scaffold; BMP-2; Natural latex; Protein P-1; SNAKE-VENOM; GLUE; CELL; COMPOSITES; VIABILITY; BMP-2;
D O I
10.1016/j.acthis.2015.03.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tissue engineering has special interest in bone tissue aiming at future medical applications Studies have focused on recombinant human bone morphogenetic protein-2 (rhBMP-2) and natural latex proteins due to the osteogenic properties of rhBMP-2 and the angiogenic characteristic of fraction 1 protein (P-1) extracted from the rubber tree Hevea brasiliensis. Furthermore, heterologous fibrin sealant (FS) has been shown as a promising alternative in regenerative therapies. The aim of this study was to evaluate these substances for the repair of bone defects in rats. A bone defect measuring 3 mm in diameter was created in the proximal metaphysis of the left tibia of 60 rats and was implanted with rhBMP-2 or P-1 in combination with a new heterologous FS derived from snake venom. The animals were divided into six groups: control (unfilled bone defect), rhBMP-2 (defect filled with 5 mu g rhBMP-2), P-1 (defect filled with 5 mu g P-1), FS (defect filled with 8 mu g FS), FS/rhBMP-2 (defect filled with 8 mu g FS and 5 mu g rhBMP-2), FS/P-1 (defect filled with 8 mu g FS and 5 mu g P-1). The animals were sacrificed 2 and 6 weeks after surgery. The newly formed bone projected from the margins of the original bone and exhibited trabecular morphology and a disorganized arrangement of osteocyte lacunae. Immunohistochemical analysis showed intense expression of osteocalcin in all groups. Histometric analysis revealed a significant difference in all groups after 2 weeks (p < 0.05), except for the rhBMP-2 and FS/rhBMP-2 groups (p > 0.05). A statistically significant difference (p < 0.05) was observed in all groups after 6 weeks in relation to the volume of newly formed bone in the surgical area. In conclusion, the new heterologous fibrin sealant was found to be biocompatible and the combination with rhBMP-2 showed the highest osteogenic and osteoconductive capacity for bone healing. These findings suggest a promising application of this combination in the regeneration surgery. (C) 2015 Elsevier GmbH. All rights reserved.
引用
收藏
页码:288 / 296
页数:9
相关论文
共 50 条
  • [1] Administration of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) and Chitosan Scaffold in calvarial bone defects in Wistar rats
    Sanjaya, I. Gusti Putu Hendra
    Maliawan, Sri
    Sudarsa, I. Wayan
    Mahadewa, Tjokorda Gde Bagus
    BALI MEDICAL JOURNAL, 2024, 13 (02) : 750 - 754
  • [2] Bone formation with use of rhBMP-2 - (Recombinant human bone morphogenetic protein-2)
    Zegzula, HD
    Buck, DC
    Brekke, J
    Wozney, JM
    Hollinger, JO
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1997, 79A (12): : 1778 - 1790
  • [3] Bone regeneration using recombinant human bone morphogenetic protein-2 (rhBMP-2) in alveolar defects of primate mandibles
    Marukawa, E
    Asahina, I
    Oda, M
    Seto, I
    Alam, MI
    Enomoto, S
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2001, 39 (06): : 452 - 459
  • [4] The use of recombinant human bone morphogenetic protein-2(rhBMP-2)in maxillofacial trauma
    A.S.Herford
    中华创伤杂志英文版, 2017, 20 (01)
  • [5] Repair of calvarial nonunions by crude bovine bone morphogenetic protein (bBMP) and introduction of recombinant human bone morphogenetic protein-2 (rhBMP-2)
    Lee, JH
    JOURNAL OF DENTAL RESEARCH, 1997, 76 (05) : 1186 - 1186
  • [6] Ridge augmentation utilizing recombinant human bone morphogenetic protein-2 (rhBMP-2)
    Barboza, EP
    Duarte, MEL
    Neto, LGMC
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : B145 - B145
  • [7] Local Sustained Delivery of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2)
    McKay, Bill
    2009 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-20, 2009, : 236 - 237
  • [8] Applications of recombinant human bone morphogenetic protein-2 (rhBMP-2) in craniofacial surgery
    Carstens, M. H.
    CRANIOFACIAL SURGERY: PROCEEDINGS OF THE TWELFTH INTERNATIONAL CONGRESS OF THE INTERNATIONAL SOCIETY OF CRANIOFACIAL SURGERY, 2007, : 3 - 6
  • [9] Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2)
    Sellers, RS
    Zhang, RW
    Glasson, SS
    Kim, HD
    Peluso, D
    D'Augusta, DA
    Beckwith, K
    Morris, EA
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2000, 82A (02): : 151 - 160
  • [10] Bone morphogenetic proteins in orthopaedic trauma: recent clinical findings with human bone morphogenetic protein-2 (rhBMP-2)
    Patel, A. D.
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 : S1 - S5